Recombinant Bacillus halodurans oligosaccharide reducing-end xylanase 8A

Cat. No.: X23-08-YM323

Recombinant Bacillus halodurans oligosaccharide reducing-end xylanase 8A

Synonym: BhRex8A; Beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose reducing-end xylanase

  • Enzyme Commission Number: 3.2.1.156
Product Size
1 mg; 2 mg; 3 mg; 6 mg
Price
Datasheet
MSDS
Properties
Description
Recombinant Bacillus halodurans oligosaccharide reducing-end xylanase 8A produced by Escherichia coli, involves the hydrolysis of 1-4-β-xylose residues specifically from the reducing end of oligosaccharides.
Expression System
Escherichia coli
Species
Bacillus halodurans
Concentration
1 mg/mL
Form
Liquid
Purity
≥90%, determined by SDS-PAGE.
Activity
Oligosaccharide reducing-end xylanases
Buffer
35 mM NaHepes buffer (pH 7.5), 750 mM NaCl, 200 mM imidazole, 3.5 mM CaCl2, and 25% (v/v) glycerol
Applications
Recombinant Bacillus halodurans oligosaccharide reducing-end xylanase 8A can be used for glycobiology research. It has the ability to hydrolyze xylooligosaccharides.
Storage
Store at -20°C.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0